HP adopts anti-Xerox poison pill

HP Inc has implemented a shareholder rights plan, otherwise known as a poison pill, ostensibly to prevent Xerox from acquiring a significant stake in the company.


To continue reading this article, you must have a paid membership.

Join now from just £5

Existing paying members, please log in to access the full story.


If you are not a paying member, sign up now: